Alzheimer's drug development: What's in the pipeline?

More than five million Americans are living with Alzheimer’s disease –and many millions more are eagerly awaiting new medications to treat it. We often hear the Alzheimer’s drug development pipeline is dry, but that’s not necessarily true according to a new report.
Published: 1:15 PM EDT July 10, 2019
Updated: 1:15 PM EDT July 10, 2019